1. Pembrolizumab, lenalidomide and dexamethasone post autologous transplant in patients with high‐risk multiple myeloma. Issue 11 (17th September 2021) Authors: Biran, Noa; Gourna Paleoudis, Elli; Feinman, Rena; Vesole, David H.; Zenreich, Joshua; Wang, Shuqi; Ahn, Jaeil; Bansal, Meena; Rowley, Scott; Donato, Michele; Pecora, Andrew L.; Richter, Joshua; Anand, Palka; McBride, Laura; Ivanovski, Kristin; Korngold, Robert; Siegel, David S. Journal: American journal of hematology Issue: Volume 96:Issue 11(2021) Page Start: E430 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗